Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedAdvisor provides a commercialized digital health platform used by over 37,000 pharmacies globally to improve medication adherence and patient outcomes. The company has demonstrated success in supporting vaccine programs and long-term therapy adherence through predictive support tools. Recognized with industry awards for technology innovation in pharmacy automation. No clinical trial results as it does not develop therapeutics. MedAdvisor delivers leading-edge digital solutions that empower pharmacies and pharmaceutical companies to drive better patient outcomes through improved medication management. Its core offering—a robust software suite—enables automated prescription refills/reminders and personalized interventions at scale. With more than three decades of expertise following its merger with Adheris Health into “MedAdvisor Solutions,” it now partners globally across >37k pharmacies including nearly every major pharma brand. The company’s recent innovations include an AI-powered Medication Advisor tool designed to further individualize care pathways for patients managing chronic therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedAdvisor.